isoquercitrin: Clinical Trials

1 trial of isoquercitrin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Unknown 1
Phase 21Unknown 1

Follow isoquercitrin: new trials by email Literature Review of isoquercitrin trials Research Report on isoquercitrin

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Isoquercetin as an Adjunct Therapy in Patients With Kidney Cancer Receiving First-line Sunitinib: a Phase I/II Trial
Sunitinib, Isoquercetin, Placebo - Renal Cell Carcinoma, Kidney Cancer
Phase 1 / Phase 2UnknownConsorzio Oncotech1042016-11-012017-01-18

Conditions studied

Carcinoma, Renal Cell (1)  ·  Fatigue (1)  ·  Kidney Neoplasms (1)

Sponsors

Consorzio Oncotech (1)

Countries

Italy (1)

Top investigators

Giuseppe Di Lorenzo, MD (1)

Results publications

PMID 21277078, PMID 22045104, PMID 23747347

NIH funding

2015 (1)